Nimish Vakil1, Börje Wernersson2, Lis Ohlsson2, John Dent3. 1. University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. 2. AstraZeneca R&D, Mölndal, Sweden. 3. Royal Adelaide Hospital & University of Adelaide, Adelaide, South Australia, Australia.
Abstract
BACKGROUND: Symptomatically 'silent' gastro-oesophageal reflux disease (GORD) may be underdiagnosed. OBJECTIVE: To determine the prevalence of untreated GORD without heartburn and/or regurgitation in primary care. METHODS: Patients were included if they had frequent upper gastrointestinal symptoms and had not taken a proton pump inhibitor in the previous 2 months (Diamond study: NCT00291746). GORD was diagnosed based on the presence of reflux oesophagitis, pathological oesophageal acid exposure, and/or a positive symptom-acid association probability. Patients completed the Reflux Disease Questionnaire (RDQ) and were interviewed by physicians using a prespecified symptom checklist. RESULTS: GORD was diagnosed in 197 of 336 patients investigated. Heartburn and/or regurgitation were reported in 84.3% of patients with GORD during the physician interviews and in 93.4% of patients with GORD when using the RDQ. Of patients with heartburn and/or regurgitation not identified at physician interview, 58.1% (18/31) reported them at a 'troublesome' frequency and severity on the RDQ. Nine patients with GORD did not report heartburn or regurgitation either at interview or on the RDQ. CONCLUSIONS: Structured patient-completed questionnaires may help to identify patients with GORD not identified during physician interview. In a small proportion of consulting patients, heartburn and regurgitation may not be present in those with GORD.
BACKGROUND: Symptomatically 'silent' gastro-oesophageal reflux disease (GORD) may be underdiagnosed. OBJECTIVE: To determine the prevalence of untreated GORD without heartburn and/or regurgitation in primary care. METHODS:Patients were included if they had frequent upper gastrointestinal symptoms and had not taken a proton pump inhibitor in the previous 2 months (Diamond study: NCT00291746). GORD was diagnosed based on the presence of reflux oesophagitis, pathological oesophageal acid exposure, and/or a positive symptom-acid association probability. Patients completed the Reflux Disease Questionnaire (RDQ) and were interviewed by physicians using a prespecified symptom checklist. RESULTS: GORD was diagnosed in 197 of 336 patients investigated. Heartburn and/or regurgitation were reported in 84.3% of patients with GORD during the physician interviews and in 93.4% of patients with GORD when using the RDQ. Of patients with heartburn and/or regurgitation not identified at physician interview, 58.1% (18/31) reported them at a 'troublesome' frequency and severity on the RDQ. Nine patients with GORD did not report heartburn or regurgitation either at interview or on the RDQ. CONCLUSIONS: Structured patient-completed questionnaires may help to identify patients with GORD not identified during physician interview. In a small proportion of consulting patients, heartburn and regurgitation may not be present in those with GORD.
Authors: M J Shaw; N J Talley; T J Beebe; T Rockwood; R Carlsson; S Adlis; A M Fendrick; R Jones; J Dent; P Bytzer Journal: Am J Gastroenterol Date: 2001-01 Impact factor: 10.864
Authors: Jae Hee Cho; Hee Man Kim; Geun Jun Ko; Myoung Lyeol Woo; Chang Mo Moon; Yu Jin Kim; Ki Jun Han; Si Young Song; Hyeon Geun Cho Journal: J Gastroenterol Hepatol Date: 2011-06 Impact factor: 4.029
Authors: R Carlsson; J Dent; E Bolling-Sternevald; F Johnsson; O Junghard; K Lauritsen; S Riley; L Lundell Journal: Scand J Gastroenterol Date: 1998-10 Impact factor: 2.423
Authors: G N Tytgat; K McColl; J Tack; G Holtmann; R H Hunt; P Malfertheiner; A P S Hungin; H K Batchelor Journal: Aliment Pharmacol Ther Date: 2007-10-31 Impact factor: 8.171
Authors: S V van Zanten; N Flook; N J Talley; N Vakil; K Lauritsen; E Bolling-Sternevald; T Persson; E Björck; L-E Svedberg Journal: Aliment Pharmacol Ther Date: 2007-09-01 Impact factor: 8.171
Authors: Michael Shaw; John Dent; Timothy Beebe; Ola Junghard; Ingela Wiklund; Tore Lind; Folke Johnsson Journal: Health Qual Life Outcomes Date: 2008-04-30 Impact factor: 3.186